188 related articles for article (PubMed ID: 1457278)
1. Overlapping syndromes, undifferentiated connective tissue disease, and other fibrosing conditions.
Kallenberg CG
Curr Opin Rheumatol; 1992 Dec; 4(6):837-42. PubMed ID: 1457278
[TBL] [Abstract][Full Text] [Related]
2. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.
Margaux J; Hayem G; Palazzo E; Chazerain P; De Bandt M; Haim T; Kahn MF; Meyer O
Rev Rhum Engl Ed; 1998 Jun; 65(6):378-86. PubMed ID: 9670329
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse.
Amigues JM; Cantagrel A; Abbal M; Mazieres B
J Rheumatol; 1996 Dec; 23(12):2055-62. PubMed ID: 8970041
[TBL] [Abstract][Full Text] [Related]
4. Anti-RNP immunity: implications for tissue injury and the pathogenesis of connective tissue disease.
Keith MP; Moratz C; Tsokos GC
Autoimmun Rev; 2007 Mar; 6(4):232-6. PubMed ID: 17317614
[TBL] [Abstract][Full Text] [Related]
5. Does mixed connective tissue disease exist? Yes.
Aringer M; Steiner G; Smolen JS
Rheum Dis Clin North Am; 2005 Aug; 31(3):411-20, v. PubMed ID: 16084315
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in the pathogenesis of mixed connective tissue disease.
Greidinger EL; Hoffman RW
Rheum Dis Clin North Am; 2005 Aug; 31(3):437-50, vi. PubMed ID: 16084317
[TBL] [Abstract][Full Text] [Related]
7. Anti-(U1) small nuclear RNA antibodies in anti-small nuclear ribonucleoprotein sera from patients with connective tissue diseases.
van Venrooij WJ; Hoet R; Castrop J; Hageman B; Mattaj IW; van de Putte LB
J Clin Invest; 1990 Dec; 86(6):2154-60. PubMed ID: 1701452
[TBL] [Abstract][Full Text] [Related]
8. [Mixed connective tissue disease--etiology, pathogenesis, clinical significance, treatment].
Zdrojewicz Z; Budzyń-Kozioł E; Puławska J
Postepy Hig Med Dosw; 1999; 53(5):751-66. PubMed ID: 10645148
[TBL] [Abstract][Full Text] [Related]
9. Clinical associations with autoantibody reactivities to individual components of U1 small nuclear ribonucleoprotein.
Kaneko Y; Suwa A; Hirakata M; Ikeda Y; Kuwana M
Lupus; 2010 Mar; 19(3):307-12. PubMed ID: 20015915
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease.
Ikeda K; Takasaki Y; Hirokawa K; Takeuchi K; Hashimoto H
J Rheumatol; 2003 May; 30(5):998-1005. PubMed ID: 12734895
[TBL] [Abstract][Full Text] [Related]
11. Close association of anti-U1 ribonucleoprotein antibody with drug allergy in patients with connective tissue diseases.
Ashida R; Asano Y; Tamaki Z; Tomita M; Kawashima T; Aakamata K; Sato S
J Dermatol Sci; 2010 Oct; 60(1):56-7. PubMed ID: 20837391
[No Abstract] [Full Text] [Related]
12. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
Komatireddy GR; Wang GS; Sharp GC; Hoffman RW
J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
[TBL] [Abstract][Full Text] [Related]
13. A new conformational epitope generated by the binding of recombinant 70-kd protein and U1 RNA to anti-U1 RNP autoantibodies in sera from patients with mixed connective tissue disease.
Murakami A; Kojima K; Ohya K; Imamura K; Takasaki Y
Arthritis Rheum; 2002 Dec; 46(12):3273-82. PubMed ID: 12483732
[TBL] [Abstract][Full Text] [Related]
14. [Evolution of connective tissue diseases with anti-ribonucleoprotein antibodies (in 28 patients) (author's transl)].
Benhamou CL; Amor B; Menkes CJ; Delbarre F
Ann Med Interne (Paris); 1982; 133(2):72-9. PubMed ID: 6979281
[TBL] [Abstract][Full Text] [Related]
15. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G
J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064
[TBL] [Abstract][Full Text] [Related]
16. Antibodies from patients with mixed connective tissue disease react with heterogeneous nuclear ribonucleoprotein or ribonucleic acid (hnRNP/RNA) of the nuclear matrix.
Fritzler MJ; Ali R; Tan EM
J Immunol; 1984 Mar; 132(3):1216-22. PubMed ID: 6198384
[TBL] [Abstract][Full Text] [Related]
17. Sicca symptoms and anti-SSA/Ro antibodies are common in mixed connective tissue disease.
Setty YN; Pittman CB; Mahale AS; Greidinger EL; Hoffman RW
J Rheumatol; 2002 Mar; 29(3):487-9. PubMed ID: 11908561
[TBL] [Abstract][Full Text] [Related]
18. Raynaud's phenomenon in mixed connective tissue disease.
Grader-Beck T; Wigley FM
Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319
[TBL] [Abstract][Full Text] [Related]
19. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
20. Detection of autoantibodies in a quantitative immunoassay using recombinant ribonucleoprotein antigens.
Habets WJ; Hoet MH; Sillekens PT; De Rooij DJ; Van de Putte LB; Van Venrooij WJ
Clin Exp Immunol; 1989 May; 76(2):172-7. PubMed ID: 2527098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
